Discover Expensify’s Q3 2025 earnings highlights, customer migration updates, and AI-driven product advancements.

To maximize value and strategic impact, finance leaders must ensure tech investments not only drive efficiency but align with ...

Discover the 5 stages of product-market fit, how to identify your business's stage, and strategies to drive sustainable ...

Discover Robinhood’s Q3 2025 record earnings, global expansion, and product innovation in trading, banking, and prediction markets.

Q3 2025 Management View CEO William Wagner stated that "Semrush reported a strong quarter with revenue of $112.1 million, non ...

Temporary space provider WillScot (NASDAQ:WSC) in Q3 CY2025, with sales falling 5.8% year on year to $566.8 million. Next ...

Operator: Good day, everyone, and welcome to the Global Partners Third Quarter 2025 Financial Results Conference Call. Today ...

As of September 30, 2025, Corvus had cash, cash equivalents and marketable securities of $65.7 million as compared to $52.0 million as of December 31, 2024. Consistent with last quarter, Corvus ...

LB Pharmaceuticals Inc ('LB Pharmaceuticals” or the 'Company”) (Nasdaq: LBRX) today announced financial results for the third quarter ended on September 30, 2025 and provided recent corporate updates.

Full-year retail volume guidance remains negative — Management reiterated expectations for MasterCraft segment retail to be down between 5%-10% for fiscal 2026 (period ending June 30, 2026), ...

Treace Medical Concepts, Inc. (NASDAQ: TMCI) Q3 2025 Earnings Call Transcript November 7, 2025 ...

Surrozen, Inc. ('Surrozen” or the 'Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with ...